GLP-1 receptor agonists (GLP-1 RAs) agonists have a suggested multi-mechanistic role in the treatment of steatosis through each of the brain, adipose tissue, liver, pancreas, and gastrointestinal tract [10,11,12]. Here, GLP1R is linked to steatosis.